This 3D medical animation introduces a highly targeted anti-cancer drug and explains Oncology MOA Animation. It uses color design to differentiate intracellular and extracellular environments. A custom animation rig depicts realistic microtubule synthesis and destruction. A detailed, interactive simulation of cell division helps viewers understand the cellular processes. For a comprehensive understanding of molecular mechanisms, this animation helps physicians and patients understand complex medical conditions.
Drug MoA and approval segment expected to account for the largest share of the market in 2016
Pharma companies can utilize drug moA and approval as a cost-effective means to control access to high-priced drugs. However, payers may also use other market access strategies, such as formulary management. This article will examine these strategies and the factors that contribute to their success. Here are the main factors driving the oncology moa market in 2016.
The drug sales revenue of oncology moas is significant. The market size for postapproval revenue ranges from $204.1 million to $22 275.0 million. All 10 drugs are protected by patents and market exclusivity, and the median time since approval is 4 years. On the other hand, prior studies suggest that the average duration of market exclusivity for oncology drugs is 14.3 years.
The growth in the oncology moa market is driven by the emergence of biosimilar drugs. Three of these drugs have received approval in the U.S., including Abbvie’s Imbruvica. These drugs accounted for approximately 27% of J&J’s total oncology drug sales in 2016.
Cancer immunotherapy is one segment that offers a strong growth potential in established markets. As cancer treatments are becoming increasingly advanced, the manufacturers are expanding their geographic reach and setting to offer the therapies to patients in need of additional treatment options. The unmet need for immunotherapy remains high. This segment will need true transformative therapies to achieve success. Its key indications include multiple myeloma, HER2+ breast cancer, prostate cancer, and renal cell carcinoma.
Cancer is the second leading cause of death globally. This increase is the result of environmental factors, including increased pollution levels and the use of harmful chemicals. The World Health Organization predicts that the number of new cancer cases worldwide will increase from 18.1 million in 2018 to 29.4 million in 2040. As a result, rising cancer awareness will continue to favor this segment of the market over the next several years.
The costs of drug development vary. Developing a new drug for oncology patients usually costs $2.7 billion or more. This cost range is lower than that for generic small molecule drugs. The cost of drug development depends on the type of the compound. For example, biologics are generally more complex than small molecule drugs. Therefore, biosimilars have a higher price tag compared to generic small molecule drugs.
Mechanism of action (MoA) animation segment expected to grow at the highest CAGR during the forecast period
The market for medical animation is divided into several segments, including pharmaceutical companies, academic institutes, hospitals, surgical centers, and others. The segment pertaining to life science is expected to have the highest CAGR during the forecast period. Growing awareness about various types of injuries and diseases is another major driver for the market. The Asia-Pacific region is expected to witness the fastest growth during the forecast period, thanks to the entry of local players in this region and the cost-effectiveness of medical animation.
The North America region dominated the market in 2016, followed by Europe. The region is expected to witness the highest CAGR during the forecast period, due to the presence of large animation studios and a large adoption of 3D Animation technology for game development. Additionally, the growing popularity of 3D animations in online streaming platforms is driving the growth of this market. Animation makers are collaborating with game companies to create interactive stories for online streaming, such as Fortiche’s collaboration with Riot Games‘ Arcane. Other key factors driving the market growth include the deployment of 3D animation in the healthcare industry and deployment in the educational sector.
In addition to pharmaceutical companies, healthcare providers are embracing 3D animation solutions for patient engagement. The combination of their extensive experience and capabilities is translating into award-winning science work. New viruses and diseases have been making their way to the market at an alarming rate. By incorporating 3D animation solutions into healthcare video production, companies have been able to enhance doctors’ communication, train medical students, and provide marketing services to patients.
The North American region is projected to dominate the global medical animation market during the forecast period, owing to the rising healthcare expenditure and increasing number of surgeries. Other major contributors to the market growth are start-up companies and medical devices. Moreover, the Middle East & Africa region is projected to experience moderate growth during the forecast period. There are many opportunities for the market growth in the coming years.
Animation & VFX market is dominated by a few major players. However, the presence of new players in the region is increasing, and these companies are increasingly expanding their business footprint in emerging economies. Key players in the sector include Adobe Inc. and Autodesk Inc. Autodesk has announced that it will move to a subscription-based business model in June 2021. Additionally, it has seen accelerated subscriber adoption in the Asia-Pacific region. Recently, the company announced a strategic partnership with Chinese media giant SunacCulture. However, the company has mentioned that the market is not starting any films in China until six months.
Moreover, the report provides comprehensive insights into the global 3D Medical Animation Market, with both quantitative and qualitative analysis. The study includes historical data, application details, and company share profiles of the leading Players in the market. The report also includes an analysis of the leading players in the market, along with their market share and forecasts. The report includes detailed information about the latest innovations and strategies in 3D Medical Animation.
The Medical Animation market is segmented by region. The report covers the Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. The report examines key market dynamics that affect each region. The report includes country-level forecasts for each region. The impact of domestic market conditions, price variations, and government policies is assessed. The analysis also includes a comparison of regional growth rates. The report also provides insights into key trends and opportunities across the world.
In terms of revenue, the North American region dominated the market in 2016. Growing pharmaceutical companies, including biotechnology firms, are leveraging medical animation to improve the quality of their products. Increased awareness of cancer and the need for medical animations are driving this market. Additionally, the increasing prevalence of cancer and the rise in consciousness levels are driving the market’s growth. Meanwhile, the North American region is expected to experience the highest CAGR.
Oncology is the largest segment in the medical animation market. It is the most popular method of conveying health information. It has multiple applications, including delivering surgical training to doctors, explaining cellular and molecular mechanisms, and promoting healthcare products. As cancer rates continue to rise, this segment will benefit from the growing demand for enhanced marketing tools. The regional outlook for cancer moa animation is positive, with a forecast of a nearly 40% growth by 2021.
- Medical Devices
- Training / E-learning
- Character Animation
- Social Media / Marketing and Branding
- General Services
Want to know how we can help? Have questions? Have a project to discuss? Message us using the contact form below, email us at [email protected] or call us at (512) 591-8024 to meet with a member of our team today.